Index
1 Market Overview
1.1 Product Overview and Scope of Molecular Pharming
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Molecular Pharming by Type
1.3.1 Overview: Global Molecular Pharming Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Molecular Pharming Consumption Value Market Share by Type in 2022
1.3.3 Gene Gun
1.3.4 Agroinfiltration
1.3.5 Electroporation
1.3.6 Agrobacterium-Mediated Gene Transfer
1.4 Global Molecular Pharming Market by Application
1.4.1 Overview: Global Molecular Pharming Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Recombinant Antibodies
1.4.3 Hormones, Vaccines
1.4.4 Industrial Enzymes
1.4.5 Proteins & Protein-Based Materials
1.4.6 Technical Reagents
1.4.7 Nutritional Products
1.5 Global Molecular Pharming Market Size & Forecast
1.6 Global Molecular Pharming Market Size and Forecast by Region
1.6.1 Global Molecular Pharming Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Molecular Pharming Market Size by Region, (2018-2029)
1.6.3 North America Molecular Pharming Market Size and Prospect (2018-2029)
1.6.4 Europe Molecular Pharming Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Molecular Pharming Market Size and Prospect (2018-2029)
1.6.6 South America Molecular Pharming Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Molecular Pharming Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Medicago Inc
2.1.1 Medicago Inc Details
2.1.2 Medicago Inc Major Business
2.1.3 Medicago Inc Molecular Pharming Product and Solutions
2.1.4 Medicago Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medicago Inc Recent Developments and Future Plans
2.2 Meristem Therapeutics S.A. (Ventria Bioscience)
2.2.1 Meristem Therapeutics S.A. (Ventria Bioscience) Details
2.2.2 Meristem Therapeutics S.A. (Ventria Bioscience) Major Business
2.2.3 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Product and Solutions
2.2.4 Meristem Therapeutics S.A. (Ventria Bioscience) Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Meristem Therapeutics S.A. (Ventria Bioscience) Recent Developments and Future Plans
2.3 Miruku
2.3.1 Miruku Details
2.3.2 Miruku Major Business
2.3.3 Miruku Molecular Pharming Product and Solutions
2.3.4 Miruku Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Miruku Recent Developments and Future Plans
2.4 Moolec Science Limited
2.4.1 Moolec Science Limited Details
2.4.2 Moolec Science Limited Major Business
2.4.3 Moolec Science Limited Molecular Pharming Product and Solutions
2.4.4 Moolec Science Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Moolec Science Limited Recent Developments and Future Plans
2.5 mozza
2.5.1 mozza Details
2.5.2 mozza Major Business
2.5.3 mozza Molecular Pharming Product and Solutions
2.5.4 mozza Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 mozza Recent Developments and Future Plans
2.6 Nobell Foods
2.6.1 Nobell Foods Details
2.6.2 Nobell Foods Major Business
2.6.3 Nobell Foods Molecular Pharming Product and Solutions
2.6.4 Nobell Foods Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nobell Foods Recent Developments and Future Plans
2.7 Agrenvec S.L
2.7.1 Agrenvec S.L Details
2.7.2 Agrenvec S.L Major Business
2.7.3 Agrenvec S.L Molecular Pharming Product and Solutions
2.7.4 Agrenvec S.L Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Agrenvec S.L Recent Developments and Future Plans
2.8 Bright Biotech
2.8.1 Bright Biotech Details
2.8.2 Bright Biotech Major Business
2.8.3 Bright Biotech Molecular Pharming Product and Solutions
2.8.4 Bright Biotech Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bright Biotech Recent Developments and Future Plans
2.9 Core Biogenesis
2.9.1 Core Biogenesis Details
2.9.2 Core Biogenesis Major Business
2.9.3 Core Biogenesis Molecular Pharming Product and Solutions
2.9.4 Core Biogenesis Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Core Biogenesis Recent Developments and Future Plans
2.10 Diamante SRL
2.10.1 Diamante SRL Details
2.10.2 Diamante SRL Major Business
2.10.3 Diamante SRL Molecular Pharming Product and Solutions
2.10.4 Diamante SRL Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Diamante SRL Recent Developments and Future Plans
2.11 Leaf Systems International Limited
2.11.1 Leaf Systems International Limited Details
2.11.2 Leaf Systems International Limited Major Business
2.11.3 Leaf Systems International Limited Molecular Pharming Product and Solutions
2.11.4 Leaf Systems International Limited Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Leaf Systems International Limited Recent Developments and Future Plans
2.12 ORF Genetics
2.12.1 ORF Genetics Details
2.12.2 ORF Genetics Major Business
2.12.3 ORF Genetics Molecular Pharming Product and Solutions
2.12.4 ORF Genetics Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 ORF Genetics Recent Developments and Future Plans
2.13 Pfizer, Inc.
2.13.1 Pfizer, Inc. Details
2.13.2 Pfizer, Inc. Major Business
2.13.3 Pfizer, Inc. Molecular Pharming Product and Solutions
2.13.4 Pfizer, Inc. Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer, Inc. Recent Developments and Future Plans
2.14 ProdiGene Inc
2.14.1 ProdiGene Inc Details
2.14.2 ProdiGene Inc Major Business
2.14.3 ProdiGene Inc Molecular Pharming Product and Solutions
2.14.4 ProdiGene Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ProdiGene Inc Recent Developments and Future Plans
2.15 Protalix Biotherapeutics, Inc
2.15.1 Protalix Biotherapeutics, Inc Details
2.15.2 Protalix Biotherapeutics, Inc Major Business
2.15.3 Protalix Biotherapeutics, Inc Molecular Pharming Product and Solutions
2.15.4 Protalix Biotherapeutics, Inc Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Protalix Biotherapeutics, Inc Recent Developments and Future Plans
2.16 Tiamat Sciences
2.16.1 Tiamat Sciences Details
2.16.2 Tiamat Sciences Major Business
2.16.3 Tiamat Sciences Molecular Pharming Product and Solutions
2.16.4 Tiamat Sciences Molecular Pharming Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tiamat Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Molecular Pharming Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Molecular Pharming by Company Revenue
3.2.2 Top 3 Molecular Pharming Players Market Share in 2022
3.2.3 Top 6 Molecular Pharming Players Market Share in 2022
3.3 Molecular Pharming Market: Overall Company Footprint Analysis
3.3.1 Molecular Pharming Market: Region Footprint
3.3.2 Molecular Pharming Market: Company Product Type Footprint
3.3.3 Molecular Pharming Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Molecular Pharming Consumption Value and Market Share by Type (2018-2023)
4.2 Global Molecular Pharming Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Molecular Pharming Consumption Value Market Share by Application (2018-2023)
5.2 Global Molecular Pharming Market Forecast by Application (2024-2029)
6 North America
6.1 North America Molecular Pharming Consumption Value by Type (2018-2029)
6.2 North America Molecular Pharming Consumption Value by Application (2018-2029)
6.3 North America Molecular Pharming Market Size by Country
6.3.1 North America Molecular Pharming Consumption Value by Country (2018-2029)
6.3.2 United States Molecular Pharming Market Size and Forecast (2018-2029)
6.3.3 Canada Molecular Pharming Market Size and Forecast (2018-2029)
6.3.4 Mexico Molecular Pharming Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Molecular Pharming Consumption Value by Type (2018-2029)
7.2 Europe Molecular Pharming Consumption Value by Application (2018-2029)
7.3 Europe Molecular Pharming Market Size by Country
7.3.1 Europe Molecular Pharming Consumption Value by Country (2018-2029)
7.3.2 Germany Molecular Pharming Market Size and Forecast (2018-2029)
7.3.3 France Molecular Pharming Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Molecular Pharming Market Size and Forecast (2018-2029)
7.3.5 Russia Molecular Pharming Market Size and Forecast (2018-2029)
7.3.6 Italy Molecular Pharming Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Molecular Pharming Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Molecular Pharming Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Molecular Pharming Market Size by Region
8.3.1 Asia-Pacific Molecular Pharming Consumption Value by Region (2018-2029)
8.3.2 China Molecular Pharming Market Size and Forecast (2018-2029)
8.3.3 Japan Molecular Pharming Market Size and Forecast (2018-2029)
8.3.4 South Korea Molecular Pharming Market Size and Forecast (2018-2029)
8.3.5 India Molecular Pharming Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Molecular Pharming Market Size and Forecast (2018-2029)
8.3.7 Australia Molecular Pharming Market Size and Forecast (2018-2029)
9 South America
9.1 South America Molecular Pharming Consumption Value by Type (2018-2029)
9.2 South America Molecular Pharming Consumption Value by Application (2018-2029)
9.3 South America Molecular Pharming Market Size by Country
9.3.1 South America Molecular Pharming Consumption Value by Country (2018-2029)
9.3.2 Brazil Molecular Pharming Market Size and Forecast (2018-2029)
9.3.3 Argentina Molecular Pharming Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Molecular Pharming Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Molecular Pharming Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Molecular Pharming Market Size by Country
10.3.1 Middle East & Africa Molecular Pharming Consumption Value by Country (2018-2029)
10.3.2 Turkey Molecular Pharming Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Molecular Pharming Market Size and Forecast (2018-2029)
10.3.4 UAE Molecular Pharming Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Molecular Pharming Market Drivers
11.2 Molecular Pharming Market Restraints
11.3 Molecular Pharming Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Molecular Pharming Industry Chain
12.2 Molecular Pharming Upstream Analysis
12.3 Molecular Pharming Midstream Analysis
12.4 Molecular Pharming Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer